Company / SG&A Expense
CareDx, Inc. SG&A Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$107.6M
FY2025
5-year range
$75.0M / $125.1M
FY2021-FY2025
Trend
-14.0%
vs FY2024
Sector context
#129 of 152
Health Care
What the data says
CareDx, Inc.'s sg&a expense of $108M is lower than 85% of companies in the Health Care sector (FY2025). Improved from $119M to $108M over the past 2 years.
Based on SEC 10-K filings.
$108M in FY2025 with a 5-year CAGR of +17.1%.
Improved from $119M to $108M over the past 2 years.
Health Care sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +2.3%
- 5-Year CAGR
- +17.1%
- 10-Year CAGR
- -
Sector benchmark
Top 15% in Health CareTop 15% of 152This company $107.6M Sector average $182.7B
▼
-99.9% below sector average
Key checks
Key Insights
- 5-year CAGR of +17.1%, indicating consistent growth.
- In FY2025, sg&a expense decreased 14.0% year-over-year.
- Ranks #129 out of 152 companies in the Health Care sector.
- Peak sg&a expense was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 0.62 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $107.6M | -14.0% |
| FY2024 | $125.1M | +5.3% |
| FY2023 | $118.8M | +18.4% |
| FY2022 | $100.4M | +33.9% |
| FY2021 | $75.0M | +53.6% |
| FY2020 | $48.8M | +33.6% |
| FY2019 | $36.5M | +59.0% |
| FY2018 | $23.0M | +14.3% |
| FY2017 | $20.1M | -3.0% |
| FY2016 | $20.7M | +69.2% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026